John Oyler, Chief Executive Officer at BeOne Medicines, sold ONC on Jun 16, 2026
Data as of Oct 16
- Traded
- Jun 16, 2026
- Disclosed
- Jun 18, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
ONC since disclosure
+36.6%
after the sale
Similar stocks (XLV) since disclosure
+18.3%
XLV — its sector index fund
Change in closing price from Jun 18, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLJohn Oyler Chief Executive OfficerONC BeOne Medicines Ltd.$437Kdisclosed Jun 18 · filed 2 days after the trade
- ▼ SELLJohn Oyler Chief Executive OfficerONC BeOne Medicines Ltd.$455Kdisclosed Jun 18 · filed 2 days after the trade